Published in Am J Kidney Dis on March 01, 2010
Metabolic complications in elderly adults with chronic kidney disease. J Am Geriatr Soc (2012) 2.44
Aging, diabetes, and the public health system in the United States. Am J Public Health (2012) 1.94
Chronic kidney disease and the risk of end-stage renal disease versus death. J Gen Intern Med (2010) 1.66
Kidney dysfunction and cognitive decline in women. Clin J Am Soc Nephrol (2012) 1.65
Association of cumulatively low or high serum calcium levels with mortality in long-term hemodialysis patients. Am J Nephrol (2010) 1.52
Prevalence of anemia in chronic kidney disease in the United States. PLoS One (2014) 1.33
Impact of age on outcomes after initial therapy with chemotherapy and different chemoimmunotherapy regimens in patients with chronic lymphocytic leukemia: results of sequential cancer and leukemia group B studies. J Clin Oncol (2012) 1.27
Kidney function and prevalent and incident frailty. Clin J Am Soc Nephrol (2013) 1.16
Estimation of glomerular filtration rate from serum creatinine and cystatin C in octogenarians and nonagenarians. BMC Nephrol (2013) 1.08
Comparison of CKD awareness in a screening population using the Modification of Diet in Renal Disease (MDRD) study and CKD Epidemiology Collaboration (CKD-EPI) equations. Am J Kidney Dis (2011) 1.04
Nondisease-specific problems and all-cause mortality among older adults with CKD: the REGARDS Study. Clin J Am Soc Nephrol (2014) 1.01
Klotho and the aging process. Korean J Intern Med (2011) 1.01
High burden and unmet patient needs in chronic kidney disease. Int J Nephrol Renovasc Dis (2012) 1.00
Enhancing collaborative pharmaceutical care for patients with chronic kidney disease: survey of community pharmacists. Can J Hosp Pharm (2014) 1.00
Adoption of clinical decision support in multimorbidity: a systematic review. JMIR Med Inform (2015) 0.99
Cardiovascular disease in chronic kidney disease: data from the Kidney Early Evaluation Program (KEEP). Curr Diab Rep (2011) 0.98
End stage and chronic kidney disease: associations with renal cancer. Front Oncol (2012) 0.98
Chronic kidney disease and cardiovascular complications. Heart Fail Rev (2015) 0.95
Chronic kidney disease in octogenarians. Clin J Am Soc Nephrol (2011) 0.92
A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease. J Nucl Cardiol (2012) 0.92
Outcomes of Elderly Patients after Predialysis Vascular Access Creation. J Am Soc Nephrol (2015) 0.91
Urinary uromodulin, kidney function, and cardiovascular disease in elderly adults. Kidney Int (2015) 0.91
Long-term evolution of renal function in patients with type 2 diabetes mellitus: a registry-based retrospective cohort study. BMJ Open (2013) 0.89
The new comorbidity index for predicting survival in elderly dialysis patients: a long-term population-based study. PLoS One (2013) 0.88
Left Ventricular Hypertrophy in Chronic Kidney Disease Patients: From Pathophysiology to Treatment. Cardiorenal Med (2015) 0.87
What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease? BMC Nephrol (2015) 0.83
Comorbid Heart Failure and Renal Impairment: Epidemiology and Management. Cardiorenal Med (2012) 0.83
Epidemiology of diabetes and diabetes complications in the elderly: an emerging public health burden. Curr Diab Rep (2013) 0.83
GPs' views on managing advanced chronic kidney disease in primary care: a qualitative study. Br J Gen Pract (2015) 0.82
Prevalence and determinants of chronic kidney disease in community-dwelling elderly by various estimating equations. BMC Public Health (2012) 0.80
Medication safety and chronic kidney disease in older adults prescribed metformin: a cross-sectional analysis. BMC Nephrol (2014) 0.80
Resistance to Recombinant Human Erythropoietin Therapy in a Rat Model of Chronic Kidney Disease Associated Anemia. Int J Mol Sci (2015) 0.79
Competing-risk analysis of death and dialysis initiation among elderly (≥80 years) newly referred to nephrologists: a French prospective study. BMC Nephrol (2013) 0.79
The association between individual counselling and health behaviour change: the See Kidney Disease (SeeKD) targeted screening programme for chronic kidney disease. Can J Kidney Health Dis (2016) 0.78
Age influence on renalase and catecholamines concentration in hypertensive patients, including maintained dialysis. Clin Interv Aging (2016) 0.78
Assessing key cost drivers associated with caring for chronic kidney disease patients. BMC Health Serv Res (2016) 0.78
Primary glomerular diseases in the elderly. World J Nephrol (2015) 0.77
Predicting mortality in older adults with kidney disease: a pragmatic prediction model. J Am Geriatr Soc (2015) 0.77
Improvement in Renal Function and Reduction in Serum Uric Acid with Intensive Statin Therapy in Older Patients: A Post Hoc Analysis of the SAGE Trial. Drugs Aging (2015) 0.76
Prevalence and complications of chronic kidney disease in a representative elderly population in Iceland. Nephrol Dial Transplant (2015) 0.76
Importance of antiresorptive therapies for patients with bone metastases from solid tumors. Cancer Manag Res (2012) 0.76
Macrophage Migration Inhibitory Factor in Clinical Kidney Disease. Front Immunol (2016) 0.76
An observational study of the quality of care for chronic kidney disease: a Buffalo and Albany, New York metropolitan area study. BMC Nephrol (2015) 0.75
Is chronic kidney disease an adverse factor in lung cancer clinical outcome? A propensity score matching study. Thorac Cancer (2017) 0.75
Provision of care for chronic kidney disease by non-nephrologists in a developing nation: a national survey. BMJ Open (2016) 0.75
Cystatin C and the Risk of Frailty and Mortality in Older Men. J Gerontol A Biol Sci Med Sci (2016) 0.75
Managing Complexity in Older Patients with CKD. Clin J Am Soc Nephrol (2017) 0.75
Chronic kidney disease: identification and management in primary care. Pragmat Obs Res (2016) 0.75
Reduced Cardiovascular Mortality Associated with Early Vascular Access Placement in Elderly Patients with Chronic Kidney Disease. Am J Nephrol (2016) 0.75
Perspectives on optimizing care of patients in multidisciplinary chronic kidney disease clinics. Can J Kidney Health Dis (2016) 0.75
The Continued Quest for Optimal BP Targets in Older Adults with Kidney Disease. Clin J Am Soc Nephrol (2016) 0.75
Awareness and knowledge among internal medicine house-staff for dose adjustment of commonly used medications in patients with CKD. BMC Nephrol (2017) 0.75
The prevalence of chronic kidney disease in apparently healthy retired subjects in asaba, Nigeria. Ann Med Health Sci Res (2014) 0.75
Prognostic Significance of Left Ventricular Mass Index and Renal Function Decline Rate in Chronic Kidney Disease G3 and G4. Sci Rep (2017) 0.75
A nationwide cross-sectional survey on prevalence, management and pharmacoepidemiology patterns on hypertension in Chinese patients with chronic kidney disease. Sci Rep (2016) 0.75
StatSensor-i point-of-care creatinine analyzer may identify patients at high-risk of contrast-induced nephropathy. Exp Ther Med (2017) 0.75
A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension (2003) 63.78
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med (2004) 49.19
Prevalence of chronic kidney disease in the United States. JAMA (2007) 38.98
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 32.81
Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med (2005) 15.30
Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci (2004) 12.46
Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis (2007) 7.86
Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med (2004) 7.79
An epidemic of chronic kidney disease: fact or fiction? Nephrol Dial Transplant (2008) 7.23
Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol (2007) 6.00
Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med (2005) 4.57
Trends in aging--United States and worldwide. MMWR Morb Mortal Wkly Rep (2003) 4.16
When laboratories report estimated glomerular filtration rates in addition to serum creatinines, nephrology consults increase. Kidney Int (2009) 3.70
Polypharmacy and prescribing quality in older people. J Am Geriatr Soc (2006) 3.39
Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int (2003) 2.77
Screening for CKD with eGFR: doubts and dangers. Clin J Am Soc Nephrol (2008) 2.41
Sensitivity of billing claims for cardiovascular disease events among kidney transplant recipients. Clin J Am Soc Nephrol (2009) 2.17
Prevalence and factors associated with CKD: a population study from Beijing. Am J Kidney Dis (2008) 2.09
Gadolinium and nephrogenic systemic fibrosis. Kidney Int (2007) 2.01
Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: evidence for lack of physician awareness of chronic kidney disease. J Am Soc Nephrol (2005) 1.98
CKD in the elderly--old questions and new challenges: World Kidney Day 2008. Am J Kidney Dis (2008) 1.93
Chronic kidney disease in the elderly--how to assess risk. N Engl J Med (2005) 1.81
Cystatin-C and mortality in elderly persons with heart failure. J Am Coll Cardiol (2005) 1.79
Association of oral sodium phosphate purgative use with acute kidney injury. J Am Soc Nephrol (2007) 1.72
Relationship between vascular disease and age-associated changes in the human kidney. Kidney Int (1987) 1.68
Standardization of serum creatinine and estimated GFR in the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2008) 1.50
The Kidney Early Evaluation Program (KEEP): program design and demographic characteristics of the population. Am J Kidney Dis (2008) 1.46
Effects of aging on the renal glomerulus. Am J Med (1986) 1.44
Cystatin-C and inflammatory markers in the ambulatory elderly. Am J Med (2005) 1.41
eGFR: is it ready for early identification of CKD? Clin J Am Soc Nephrol (2008) 1.35
Estimated glomerular filtration rate: time for a performance review? Kidney Int (2009) 1.11
High prevalence of stage 3 chronic kidney disease in older adults despite normal serum creatinine. J Gen Intern Med (2008) 0.93
Risk factors for premature peripheral vascular disease: results for the National Health and Nutritional Survey, 1999-2002. J Vasc Surg (2006) 0.93
Cardiovascular implications of chronic kidney disease in older adults. Drugs Aging (2008) 0.90
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension (2003) 63.78
A controlled trial of renal denervation for resistant hypertension. N Engl J Med (2014) 14.22
Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med (2002) 12.95
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med (2008) 11.61
Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med (2013) 8.74
Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48
Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N Engl J Med (2013) 7.54
Combined angiotensin inhibition for the treatment of diabetic nephropathy. N Engl J Med (2013) 7.29
Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA (2005) 6.81
Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial. Lancet (2012) 6.69
Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors. N Engl J Med (2014) 5.93
'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis (2012) 5.70
Metformin: an update. Ann Intern Med (2002) 5.62
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47
Cancer after kidney transplantation in the United States. Am J Transplant (2004) 5.08
Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA (2010) 5.06
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation (2006) 4.61
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care (2007) 4.30
Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med (2003) 4.08
Fat distribution in men with HIV infection. J Acquir Immune Defic Syndr (2005) 4.02
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care (2013) 3.90
Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension (2006) 3.89
Sleep duration among black and white Americans: results of the National Health Interview Survey. J Natl Med Assoc (2008) 3.82
Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. Arch Intern Med (2008) 3.71
Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int (2011) 3.48
Monitoring clinical changes in patients with heart failure: a comparison of methods. Am Heart J (2005) 3.26
Excerpts from the US Renal Data System 2009 Annual Data Report. Am J Kidney Dis (2010) 3.11
Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich) (2013) 2.94
US Renal Data System 2010 Annual Data Report. Am J Kidney Dis (2011) 2.90
Development and validation of a patient self-assessment score for diabetes risk. Ann Intern Med (2009) 2.85
Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study. Am J Transplant (2003) 2.83
Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. J Hypertens (2014) 2.82
Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem (2011) 2.82
Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States. Am J Kidney Dis (2005) 2.81
Acute kidney injury and cardiovascular outcomes in acute severe hypertension. Circulation (2010) 2.76
Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. Circ Cardiovasc Genet (2010) 2.76
Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care (2011) 2.75
Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the Kidney Early Evaluation Program (KEEP). Arch Intern Med (2012) 2.74
Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). Am J Kidney Dis (2003) 2.68
US Renal Data System 2013 Annual Data Report. Am J Kidney Dis (2014) 2.68
Care of the potential organ donor. N Engl J Med (2004) 2.66
Resistant hypertension: an overview of evaluation and treatment. J Am Coll Cardiol (2008) 2.63
Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol (2006) 2.58
US Renal Data System 2012 Annual Data Report. Am J Kidney Dis (2013) 2.54
Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int (2009) 2.52
Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort. J Acquir Immune Defic Syndr (2010) 2.47
Cardiovascular events during differing hypertension therapies in patients with diabetes. J Am Coll Cardiol (2010) 2.43
A simple algorithm to predict incident kidney disease. Arch Intern Med (2008) 2.36
The pathogenesis of diabetic nephropathy. Nat Clin Pract Endocrinol Metab (2008) 2.34
Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study. J Am Coll Cardiol (2003) 2.34
Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertension. J Hypertens (2014) 2.28
Building an academic-community partnered network for clinical services research: the Community Health Improvement Collaborative (CHIC). Ethn Dis (2006) 2.25
Awareness of kidney disease and relationship to end-stage renal disease and mortality. Am J Med (2012) 2.24
Diagnostic value of B-Type natriuretic peptide and chest radiographic findings in patients with acute dyspnea. Am J Med (2004) 2.23
Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney Int Suppl (2003) 2.20
Scientific Registry of Transplant Recipients: collecting, analyzing, and reporting data on transplantation in the United States. Transplant Rev (Orlando) (2013) 2.19
Excerpts from the United States Renal Data System 2006 Annual Data Report. Am J Kidney Dis (2007) 2.16
Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP). Arch Intern Med (2007) 2.14
United States Renal Data System 2008 Annual Data Report. Am J Kidney Dis (2009) 2.14
Hypertension awareness, treatment, and control in chronic kidney disease. Am J Med (2008) 2.11
Trajectories of kidney function decline in the 2 years before initiation of long-term dialysis. Am J Kidney Dis (2012) 2.10